MedPath

LUMIGAN

LUMIGAN

Discontinued
DIN Number

02245860

Drug Class

Human

Market Date

May 24, 2002

Company
HC

Allergan, Inc.

Product Information

Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.

Product Details

Health Canada regulatory and product classification information

Regulatory Identifiers
DIN Number02245860
AIG Number0147303001
Classification & Schedule
C
Drug Class
Human
S
Schedule
Prescription
A
ATC Code
S01EE03 BIMATOPROST
Product Specifications
Dosage FormSolution
Route of AdministrationOphthalmic
AHFS Classification52:40.28
Health Canada Classification

ACTIVE INGREDIENTS (1)

BIMATOPROSTActive
Strength: 0.03 %
Monograph: BIMATOPROST

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.